Product Information

BICALUTAMIDE 50 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.4163 per EA under NDC 16729002301. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jul 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BICALUTAMIDE 50 MG TABLET

Bicalutamide
$0.4163per EA

Strength

50 mg/1

NDC

16729002301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BICALUTAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078917

FDA Approved

7/6/2009

TE Code

AB

On Market Since

7/6/2009

Pharmacological Classes

Androgen Receptor Antagonists
Androgen Receptor Inhibitor

Price Statistics

The NADAC for BICALUTAMIDE 50 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4163 per EA
All-time high$0.4740 (Feb 12, 2014)
All-time low$0.2354 (Feb 20, 2019)
52-week high$0.4300
52-week low$0.3953
Median price$0.3347
Average price$0.3434
Largest weekly change+50.2% (Jul 17, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-1.7%

1M

-0.3%

3M

+1.3%

6M

+3.9%

1Y

-3.2%

3Y

+28.1%

5Y

+19.1%

All

-8.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BICALUTAMIDE 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BICALUTAMIDE 50 MG TABLET, manufactured by Accord Healthcare Inc., is $0.4163 per EA (NDC 16729002301), effective Aug 19, 2026.

How has the price of BICALUTAMIDE 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for BICALUTAMIDE 50 MG TABLET has declined 8.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BICALUTAMIDE 50 MG TABLET?

Since Nov 28, 2013, the NADAC for BICALUTAMIDE 50 MG TABLET has ranged from a low of $0.2354 (Feb 20, 2019) to a high of $0.4740 (Feb 12, 2014), with a median of $0.3347 per EA.

Are there cheaper alternatives to BICALUTAMIDE 50 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BICALUTAMIDE 50 MG TABLET, is $0.4028 per EA — about 3% below BICALUTAMIDE 50 MG TABLET.

Who manufactures BICALUTAMIDE 50 MG TABLET?

BICALUTAMIDE 50 MG TABLET (NDC 16729002301) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.